Human Polyclonal Antibody to Treat Unvaccinated Non-Hospitalized Adult Patients

Community NewsNews
30

Translate to Spanish or other 102 languages!

Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. Image for illustration purposes.
Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. Image for illustration purposes.

Mega Doctor News

- Advertisement -

EDINBURG, Texas – DHR Health is involved in a new and innovative study to use human polyclonal antibody to treat non-hospitalized patients who are >18 years of age with mild-moderate COVID-19. Safety of this human polyclonal antibody (SAB-185) has already been established. This would be the first such study in which human polyclonal antibodies will be used to treat patients with COVID-19.

“We are embarking on a new study that is FDA-approved and NIH-funded to infuse human polyclonal antibodies in non-hospitalized unvaccinated high-risk individuals who are COVID-19 positive” said Sohail Rao, MD, MA, DPhil, President & CEO, DHR Health Institute for Research & Development. “The human polyclonal antibody has been shown to neutralize both wild-type and various variants of SARS-CoV-2 virus including Delta. the primary objective of this study is to prevent hospitalization of the patients with COVID-19.”

The study entails a single treatment with either REGEN-COV monoclonal antibody or SAB-185 human polyclonal antibody which is infused intravenously. Enrollment in this study is voluntary and the patients will not be charged for this treatment and/or the follow-up. To learn more about who would qualify for this treatment, please visit this weblink: https://youtu.be/u8lubUkucNY or call COVID-19 treatment hotline (956) 362-2393 (9:00 a.m. – 5:00 p.m.; M-F) or (956) 342-2383 for more information.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Virtual lung cancer screening is just as effective as in-person screening
Next article
Local Hospital Held 3rd Annual Spooktacular Stroke Awareness 5K

More Articles

What You Need to Know About Aortic Dissection

An aortic dissection – a tear in the inner layer of the main artery – is a life-threatening emergency. It can happen with little warning, as apparently was the case with U.S. Sen. Lindsey Graham. His sudden death at age 71 was preliminarily attributed to an aortic dissection stemming from plaque buildup in his arteries.

DHR Health’s Free Seminar on Breakthrough Treatment for Stroke Survivors, Sept. 19th

DHR Health’s Neuroscience Institute will host a free seminar for stroke survivors who want improved hand and arm movement as many stroke survivors experience impaired mobility and loss of function in the arm which can significantly affect their ability to   perform everyday activities.

DHR Health Transplant Institute Bringing New Era to South Texas

Something significant is happening in medicine in the Rio Grande Valley. A level of specialized care that once routinely required Valley patients to travel hundreds of miles is now being delivered close to home — and earning recognition among leading kidney transplant programs in Texas and across the nation. DHR Health Transplant Institute has reached No. 2 in Texas and No. 16 nationally, marking an important moment for advanced medicine in South Texas.

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?
- Advertisement -